HOME Press Releases Peripheral Vascular Devices Market worth 12.63 Billion USD by 2022



Peripheral Vascular Devices Market worth 12.63 Billion USD by 2022


The report "Peripheral Vascular Devices Market by Type (Angioplasty Balloon, Stent, Catheters (Angiography, IVUS), Plaque Modification (Atherectomy, Thrombectomy), Hemodynamic Flow Alteration (Embolic Protection), IVC Filters, Guidewires) - Global Forecast to 2022", is expected to reach USD 12.63 Billion by 2022 from USD 9.09 Billion in 2017, at a CAGR of 6.8%. Factors driving the growth of this market include technological advancements in peripheral vascular devices, rising geriatric population, increasing incidence of aneurysm cases, and increasing preference for minimally invasive surgeries.

     Download PDF Brochure     View TOC      Inquiry Before Buying

Browse 217 market data Tables and 33 Figures spread through 200 Pages and in-depth TOC on "Peripheral Vascular Devices Market by Type (Angioplasty Balloon, Stent, Catheters (Angiography, IVUS), Plaque Modification (Atherectomy, Thrombectomy), Hemodynamic Flow Alteration (Embolic Protection), IVC Filters, Guidewires) - Global Forecast to 2022"
https://www.marketsandmarkets.com/Market-Reports/interventional-cardiology-peripheral-vascular-devices-market-790.html
Early buyers will receive 10% customization on reports.

Angioplasty stents are estimated to account for the largest share of the peripheral vascular devices market in 2017.

The peripheral vascular devices include angioplasty stents, angioplasty balloons, catheters, endovascular aneurysm repair stent grafts, inferior vena cava filters, hemodynamic flow alteration devices, and other devices. In 2017, the angioplasty stents segment is expected to hold the largest share of the market. Angioplasty stents are further segmented into bare-metal stents and drug-eluting stents. The drug-eluting stents segment is expected to account for the largest share of the global peripheral vascular devices market in 2017. Factors driving the growth of this subsegment are the wide range of benefits associated with the use of drug-eluting stents and the widespread availability of these devices across the globe.

The hemodynamic flow alteration devices market is estimated to grow at the highest CAGR during the forecast period.

Hemodynamic flow alteration devices are further segmented into embolic protection devices and chronic total occlusion devices. The embolic protection devices segment is expected to account for the largest share of the global peripheral vascular devices market in 2017. Market growth can largely be attributed the increasing number of endovascular surgeries, investments for new technology development, and regulatory approvals for these devices.

North America is expected to command the largest share of the market during the forecast period.

Based on region, the peripheral vascular devices market is segmented into North America, Europe, Asia Pacific, and the Rest of the World (RoW). North America is estimated to dominate the peripheral vascular devices market in 2017. This is mainly due to factors such as the rising incidence of cardiovascular diseases, growing geriatric population, and the strong presence of industry players in the region.

Key players in the peripheral vascular devices market include Medtronic (US), Boston Scientific (US), Abbott Laboratories (US), Terumo (Japan), Cordis (US), B.Braun (Germany), C.R. Bard (US), Biosensors (Singapore), and Biotronik (Germany).

About MarketsandMarkets™

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 5000 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets’s flagship competitive intelligence and market research platform, "RT" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Contact:
Mr. Rohan
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
sales@marketsandmarkets.com

We will organize an analyst call and demonstrate the latent opportunities and threats which will likely impact your business, at no cost.

Speak to Analyst


* Name :
* Business Email :
* Phone :
* Designation :
* Country:
Report MD 1254: Peripheral Vascular Devices Market by Type (Angioplasty Balloon, Stent, Catheters (Angiography, IVUS), Plaque Modification (Atherectomy, Thrombectomy), Hemodynamic Flow Alteration (Embolic Protection), IVC Filters, Guidewires) - Global Forecast to 2022
* Enter the text from the image
   to the textbox :
7 4 9 7 1  
Connect Us

Follow us on LinkedIn  Follow us on Facebook   Follow us on Twitter 
Live Chat Support


US : 1-888-600-6441

Search reports